Recent Company News

• 01:06 AM ET Jun 16, 2025
  

  bioMérieux announces an agreement to acquire the assets of Day Zero Diagnostics, a US-based infectious disease diagnostics company (€120.60, 0.00)

• 03:52 AM ET Jun 12, 2025
  

  StreetAccount Summary: EU stocks reaching new 52-week highs/lows (58 total)

• 05:24 AM ET Jun 11, 2025
  

  StreetAccount Summary: EU stocks reaching new 52-week highs/lows (74 total)

• 04:13 AM ET Jun 06, 2025
  

  StreetAccount Summary: EU stocks reaching new 52-week highs/lows (81 total)

• 04:29 AM ET Apr 17, 2025
  

  StreetAccount Summary - Trading higher/lower: EU mid-morning

• 01:32 AM ET May 07, 2025
  

  bioMerieux downgraded to sector perform from outperform at RBC Capital Markets (€117.20, 0.00)

• 02:56 AM ET Apr 17, 2025
  

  StreetAccount Summary - European pre-market trading update

• 01:08 AM ET Apr 17, 2025
  

  bioMerieux reports Q1 sales €1.10B vs FactSet €1.08B [3 est, €1.05-1.10B]; confirms FY25 sales guidance and closely monitoring evolving tariff situation (€118.30, 0.00)

• 03:33 AM ET Apr 07, 2025
  

  bioMerieux downgraded to hold from buy at TPICAP Midcap (pre-open) (€109.80, -4.90)